Pulmonary dysfunction in adults with nephropathic cystinosis.
@article{Anikster2001PulmonaryDI,
title={Pulmonary dysfunction in adults with nephropathic cystinosis.},
author={Yair Anikster and Felicitas L. Lacbawan and Mark L. Brantly and Bernadette L. Gochuico and Nilo A. Avila and William D. Travis and William A. Gahl},
journal={Chest},
year={2001},
volume={119 2},
pages={
394-401
}
}OBJECTIVE
To characterize the pulmonary dysfunction in patients with nephropathic cystinosis after renal transplantation.
DESIGN
Cross-sectional analysis of consecutive adult patients.
PATIENTS
Twelve adult, nephropathic cystinosis patients and 3 adult, ocular, nonnephropathic cystinosis patients admitted to the National Institutes of Health Clinical Center.
RESULTS
The 12 nephropathic cystinosis patients (age range, 21 to 40 years) showed an extraparenchymal pattern of restrictive lung…
51 Citations
Pulmonary dysfunction in children with Cystinosis: single center study, original article
- MedicineEgyptian Pediatric Association Gazette
- 2022
Small airway affection was detected in most of cystinosis children by means of IOS in spite of the absence of chest manifestations and suggestive history which highlight the importance of respiratory assessment and follow up of cyStinosis patients not only by history, and examination but most important pulmonary function tests.
Nephropathic Cystinosis in Adults: Natural History and Effects of Oral Cysteamine Therapy
- MedicineAnnals of Internal Medicine
- 2007
Clinicians found that a history of long-term cysteamine therapy seemed to be associated with a decreased risk for complications and death in adults with nephropathic cystinosis not treated with oral cysteamines.
Cystinosis beyond kidneys: gastrointestinal system and muscle involvement
- MedicineBMC Gastroenterology
- 2020
In addition to renal functions, extrarenal organs may be affected from cystine accumulation even in childhood, especially in patients who are incompliant to treatment, resulting in complications such as swallowing difficulty, hepatomegaly and portal hypertension.
Successful management of a neglected case of nephropathic cystinosis.
- MedicineSultan Qaboos University medical journal
- 2014
Treatment with cysteamine should be initiated rapidly and continued lifelong to prolong renal function and protect the extra-renal organs in cystinosis.
Nephropathic cystinosis in children: An overlooked disease.
- MedicineSaudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
- 2009
Corneal Cystine Crystal Scoring is a simple and reasonably sensitive method for diagnosis of nephropathic cystinosis above two years of age and may decrease it with adequate compliance after six months of treatment.
Pharmacological treatment of nephropathic cystinosis with cysteamine
- Medicine, BiologyExpert opinion on pharmacotherapy
- 2004
Since the introduction of cysteamine into the pharmacological management of cystinosis, well-treated adolescent and young adult patients have experienced normal growth and maintenance of renal glomerular function.
Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
- MedicineKidney international
- 2012
Cysteamine decreases and delays the onset of complications and improves life expectancy in cystinosis, and should be introduced as early as possible during childhood and maintained lifelong.
Cystinosis in adult and adolescent patients: Recommendations for the comprehensive care of cystinosis.
- MedicineNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia
- 2015
Natural History of Symptomatically Treated Children with Cystinosis
- Medicine
- 2012
A retrospective study on cystinotic patients who were diagnosed and treated symptomatically in children welfare teaching hospital in Baghdad from period Jun 2002 –July 2011 finds that leukocyte cystine levels are still needed to be available to confirm diagnosis in infants who have negative ocular examination and to win in the fight against this terrible disease cysteamine treatment need to been available for these patients.
Swallowing Dysfunction in 101 Patients with Nephropathic Cystinosis: Benefit of Long-Term Cysteamine Therapy
- MedicineMedicine
- 2005
It is concluded that swallowing dysfunction in cystinosis presents a risk of fatal aspiration, correlates with the presence of muscle atrophy, and, based on cross-sectional data, increases in frequency with age and number of years without cysteamine treatment.
References
SHOWING 1-10 OF 51 REFERENCES
Swallowing dysfunction in nephropathic cystinosis.
- MedicineThe New England journal of medicine
- 1990
Age-related swallowing dysfunction is a late complication of nephropathic cystinosis, probably related to muscular dysfunction, and changes in the consistency of foods, swallowing exercises, and long-term cysteamine therapy should be considered for patients with cyStinosis who have difficulty in swallowing.
Improved renal function in children with cystinosis treated with cysteamine.
- MedicineThe New England journal of medicine
- 1993
Children with cystinosis who are treated early and adequately with cysteamine have renal function that increases during the first five years of life and then declines at a normal rate, as compared with 20 years of age for the children who received partial treatment.
Neurologic complications in long-standing nephropathic cystinosis.
- MedicineArchives of neurology
- 1989
The neurologic involvement in these patients suggests that cystinosis may eventually involve the central nervous system, and the differential diagnosis must include other complications from renal failure, dialysis, and immunosuppression.
Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis.
- Medicine, BiologyThe Journal of clinical endocrinology and metabolism
- 1995
It is concluded that in addition to its other salutary effects, oral cysteamine therapy helps prevent hypothyroidism and enhances growth in patients with nephropathic cystinosis.
Distal vacuolar myopathy in nephropathic cystinosis
- MedicineAnnals of neurology
- 1994
A distal vacuolar myopathy is a common late complication of untreated nephropathic cystinosis, and the cause is unclear, although the general lysosomal defect in this disease may also affect theLysosomes within muscle fibers.
Cysteamine therapy for children with nephropathic cystinosis.
- MedicineThe New England journal of medicine
- 1987
It is concluded that oral cysteamine, by depleting cells of cystine, helps maintain renal glomerular function, improves growth, and constitutes the current treatment of choice for nephropathic cystinosis.
Pituitary-Testicular Function in Nephropathic Cystinosis
- Medicine, BiologyAnnals of Internal Medicine
- 1993
Ten patients who received renal allografts and who are currently being followed at the National Institutes of Health were seen as part of an institutional review board-approved protocol of the National Institute of Child Health and Human Development to study the complications of cystinosis after transplantation.
Parenchymal organ cystine depletion with long-term cysteamine therapy.
- MedicineBiochemical medicine and metabolic biology
- 1992
Ocular Nonnephropathic Cystinosis: Clinical, Biochemical, and Molecular Correlations
- Medicine, BiologyPediatric Research
- 2000
The molecular basis for ocular cystinosis was determined in four individuals, indicating that ocular CySTinosis is allelic with classic nephropathic cystInosis, an autosomal recessive lysosomal storage disorder characterized by photophobia due to corneal cystine crystals but absence of renal disease.
Pancreatic endocrine insufficiency in posttransplant cystinosis.
- MedicineAmerican journal of diseases of children
- 1987
The use of cystine-depleting agents should be considered in posttransplant cystinosis as an attempt to prevent potential damage to the pancreas and other organs from Cystine deposition.






